EXHIBIT J FORM OF TRANSITION SERVICES AGREEMENT TRANSITION SERVICES AGREEMENT by and between Eisai Inc. and Catalyst Pharmaceuticals, Inc. Dated as of [•]Transition Services Agreement • December 22nd, 2022 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Transition Services Agreement (this “Agreement”) dated as of [•] (the “Effective Date”), by and between Eisai Inc., a Delaware corporation (“Seller”) and Catalyst Pharmaceuticals, Inc., a Delaware corporation (“Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Exhibit H Form of Supply Agreement SUPPLY AGREEMENT between EISAI CO., LTD. and CATALYST PHARMACEUTICALS, INC. Dated as of [ • ], 2022Supply Agreement • December 22nd, 2022 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Supply Agreement (this “Agreement”) is made and entered into effective as of [ • ], 2022 (the “Effective Date”) by and between Eisai Co., Ltd., a corporation organized under the laws of Japan (“Seller”), and Catalyst Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (“Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ASSET PURCHASE AGREEMENT by and between EISAI CO., LTD. and CATALYST PHARMACEUTICALS, INC. Dated as of December 17, 2022Asset Purchase Agreement • December 22nd, 2022 • Catalyst Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and executed as of December 17, 2022, by and between Eisai Co., Ltd., a corporation organized under the laws of Japan (“Seller”) and Catalyst Pharmaceuticals, Inc., a Delaware corporation (“Buyer”). Seller and Buyer are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
